82 FR 24307 - Grant of Interim Extension of the Term of U.S. Patent No. 5,912,231; LOCILEX® (pexiganan)

DEPARTMENT OF COMMERCE
Patent and Trademark Office

Federal Register Volume 82, Issue 101 (May 26, 2017)

Page Range		24307-24307
FR Document		2017-10964

The United States Patent and Trademark Office has issued an order granting interim extension for a one-year interim extension of the term of U.S. Patent No. 5,912,231.

Federal Register, Volume 82 Issue 101 (Friday, May 26, 2017)

[Federal Register Volume 82, Number 101 (Friday, May 26, 2017)]
[Notices]
[Page 24307]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-10964]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

 Patent and Trademark Office

[Docket No.: PTO-P-2017-0023]


Grant of Interim Extension of the Term of U.S. Patent No. 
5,912,231; LOCILEX[supreg] (pexiganan)

AGENCY: United States Patent and Trademark Office, Commerce.

ACTION: Notice of Interim patent term extension.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office has issued an 
order granting interim extension for a one-year interim extension of 
the term of U.S. Patent No. 5,912,231.

FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571) 
272-7755; by mail marked to her attention and addressed to the 
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, 
Alexandria, VA 22313-1450; by fax marked to her attention at (571) 273-
7755; or by email to [email protected].

SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code, 
generally provides that the term of a patent may be extended for a 
period of up to five years if the patent claims a product, or a method 
of making or using a product, that has been subject to certain defined 
regulatory review, and that the patent may be extended for interim 
periods of up to one year if the regulatory review is anticipated to 
extend beyond the expiration date of the patent.
    On May 9, 2017, Scripps Research Institute, the patent owner of 
record, timely filed an application under 35 U.S.C. 156(d)(5) for a 
second interim extension of the term of U.S. Patent No. 5,912,231. The 
patent claims a composition of the active ingredient pexiganan of the 
human drug product LOCILEX[supreg]. The application for patent term 
extension indicates that New Drug Application (NDA) 29-930 was 
submitted to the Food and Drug Administration (FDA) on July 24, 1998.
    Review of the patent term extension application indicates that, 
except for permission to market or use the product commercially, the 
subject patent would be eligible for an extension of the patent term 
under 35 U.S.C. 156, and that the patent should be extended for one 
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory 
review period will continue beyond the extended expiration date of the 
patent, June 15, 2017, interim extension of the patent term under 35 
U.S.C. 156(d)(5) is appropriate.
    An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. 
Patent No. 5,912,231 is granted for a period of one year from the 
extended expiration date of the patent.

    Dated: May 22, 2017.
Robert Bahr,
Deputy Commissioner for Patent Examination Policy, United States Patent 
and Trademark Office.
[FR Doc. 2017-10964 Filed 5-25-17; 8:45 am]
 BILLING CODE 3510-16-P

Federal Register / Vol. 82, No. 101 / Friday, May 26, 2017 / Notices 24307

New England Fishery Management SUMMARY: The United States Patent and DEPARTMENT OF COMMERCE
Council; telephone: (978) 465–0492. Trademark Office has issued an order
SUPPLEMENTARY INFORMATION: granting interim extension for a one- Patent and Trademark Office
year interim extension of the term of
Agenda U.S. Patent No. 5,912,231. Submission for OMB Review;
The Committee will review Plan Comment Request; Trademark Trial
FOR FURTHER INFORMATION CONTACT: and Appeal Board (TTAB) Actions
Development Team (PDT) analysis
Mary C. Till by telephone at (571) 272–
regarding skate bait possession limits. The United States Patent and
7755; by mail marked to her attention
They will discuss and select preferred Trademark Office (USPTO) will submit
and addressed to the Commissioner for
alternatives for Framework 4 to the to the Office of Management and Budget
Skate Fishery Management Plan which Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313– (OMB) for clearance the following
modifies skate bait possession limits proposal for collection of information
and associated measures. The 1450; by fax marked to her attention at
(571) 273–7755; or by email to under the provisions of the Paperwork
committee will also review and discuss Reduction Act (44 U.S.C. Chapter 35).
PDT analysis, to date, regarding the Mary.Till@uspto.gov.
Agency: United States Patent and
upcoming specifications framework SUPPLEMENTARY INFORMATION: Section Trademark Office, Commerce
which would set specifications for FYs 156 of Title 35, United States Code, Title: Trademark Trial and Appeal
2018 and 2019 and would remove the generally provides that the term of a Board (TTAB) Actions
prohibition on landing barndoor skates. patent may be extended for a period of OMB Control Number: 0651–0040.
Other business, as necessary. up to five years if the patent claims a Form Number(s):
Although other non-emergency issues product, or a method of making or using
not on the agenda may come before this • PTO 2120
a product, that has been subject to • PTO 2151
group for discussion, those issues may
not be the subject of formal action
certain defined regulatory review, and • PTO 2153
during this meeting. Actions will be
that the patent may be extended for • PTO 2188
restricted to those issues specifically
interim periods of up to one year if the • PTO 2189
listed in this notice and any issues
regulatory review is anticipated to • PTO 2190
extend beyond the expiration date of the Type of Request: Revision of a
arising after publication of this notice patent.
that require emergency action under currently approved collection.
§ 305(c) of the Magnuson-Stevens On May 9, 2017, Scripps Research Number of Respondents: 78,000 per
Fishery Conservation and Management Institute, the patent owner of record, year.
Act, provided the public has been timely filed an application under 35 Average Hours per Response: Between
notified of the Council’s intent to take U.S.C. 156(d)(5) for a second interim 10 minutes (0.17 hours) and 30 minutes
final action to address the emergency. extension of the term of U.S. Patent No. (0.5 hours) to gather the necessary
5,912,231. The patent claims a information, prepare the materials, and
Special Accommodations composition of the active ingredient to submit it to the USPTO, depending
This meeting is physically accessible pexiganan of the human drug product upon the instrument used.
to people with disabilities. This meeting LOCILEX®. The application for patent Burden Hours: 15,997.67 hours.
will be recorded. Consistent with 16 term extension indicates that New Drug Cost Burden: $5,744,000.00.
U.S.C. 1852, a copy of the recording is Application (NDA) 29–930 was Needs and Uses: This information is
available upon request. Requests for submitted to the Food and Drug required by the Trademark Act of 1946,
sign language interpretation or other Administration (FDA) on July 24, 1998. Sections 13, 14, and 20, 15 U.S.C. 1063,
auxiliary aids should be directed to Review of the patent term extension 1064, and 1070, respectively. The
Thomas A. Nies, Executive Director, at application indicates that, except for information in this collection is a matter
(978) 465–0492, at least 5 days prior to permission to market or use the product of public record and is used by the
the meeting date. commercially, the subject patent would public for a variety of private business
Authority: 16 U.S.C. 1801 et seq. be eligible for an extension of the patent purposes related to establishing and
term under 35 U.S.C. 156, and that the enforcing trademark rights. This
Dated: May 22, 2017. information is important to the public,
patent should be extended for one year
Tracey L. Thompson, as required by 35 U.S.C. 156(d)(5)(B). as both common law trademark owners
Acting Deputy Director, Office of Sustainable Because the regulatory review period and Federal trademark registrants must
Fisheries, National Marine Fisheries Service. actively protect their own rights. This
will continue beyond the extended
[FR Doc. 2017–10778 Filed 5–25–17; 8:45 am] expiration date of the patent, June 15, collection includes the information
BILLING CODE 3510–22–P 2017, interim extension of the patent needed by the USPTO to review the
term under 35 U.S.C. 156(d)(5) is various types of petitions to cancel the
appropriate. registration of a mark, notices of
DEPARTMENT OF COMMERCE opposition to the registration of a mark,
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No. extensions of time to file an opposition,
Patent and Trademark Office appeals, and other papers filed in
5,912,231 is granted for a period of one
[Docket No.: PTO–P–2017–0023]
year from the extended expiration date connection with inter partes and ex
of the patent. parte proceedings.
Grant of Interim Extension of the Term Affected Public: Businesses or other
of U.S. Patent No. 5,912,231; LOCILEX® Dated: May 22, 2017. for-profits; not-for-profit institutions.
(pexiganan) Robert Bahr, Frequency: On occasion.
AGENCY: United States Patent and Deputy Commissioner for Patent Examination Respondent’s Obligation: Required to
Policy, United States Patent and Trademark Obtain or Retain Benefits.
Trademark Office, Commerce. Office. OMB Desk Officer: Nicholas A. Fraser,
ACTION: Notice of Interim patent term
[FR Doc. 2017–10964 Filed 5–25–17; 8:45 am] email: Nicholas_A._Fraser@
extension.
BILLING CODE 3510–16–P omb.eop.gov. Once submitted, the

VerDate Sep<11>2014 19:14 May 25, 2017 Jkt 241001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\26MYN1.SGM 26MYN1

Document Created: 2017-05-26 02:23:31
Document Modified: 2017-05-26 02:23:31

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of Interim patent term extension.
Contact		Mary C. Till by telephone at (571)
FR Citation		82 FR 24307

82 FR 24307 - Grant of Interim Extension of the Term of U.S. Patent No. 5,912,231; LOCILEX® (pexiganan)

DEPARTMENT OF COMMERCEPatent and Trademark Office

Federal Register Volume 82, Issue 101 (May 26, 2017)

DEPARTMENT OF COMMERCE
Patent and Trademark Office